| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/27/2005 | CA2525582A1 Synthetic nucleic acids from aquatic species |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921670 Nanostructure fabrication using microbial mandrel |
| 07/26/2005 | US6921666 Methods for generating hypermutable yeast |
| 07/26/2005 | US6921659 Gram-negative bacterial cell deficient hydrolase/protease activity for use in generating uncleaved heterologously expressed polypeptides; somatotropins |
| 07/26/2005 | US6921658 Serine protease BSSP6 |
| 07/26/2005 | US6921657 Protease variants and compositions |
| 07/26/2005 | US6921656 Comprises heat resistant hydrolase for production of glucose, isomerized sugars, oligosaccharides, liquors and fermented alchol |
| 07/26/2005 | US6921651 Process for the preparation of amino acids by using coryneform bacteria with attenuated 1-phosphofructokinase activity |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | US6921646 DNA sequence comprising signal tranduction protein for monitoring cell regulation and morphological/embryonic development; drug screening |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921635 Culture and identification media specific of different species of Candida and analysis methods |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | CA2240097C Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 07/26/2005 | CA2173115C Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carnitine |
| 07/26/2005 | CA2089552C Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 07/21/2005 | WO2005066628A1 Bioluminescent assays and cells useful therein |
| 07/21/2005 | WO2005066354A1 Fermentation of bartonella henselae for vaccine production |
| 07/21/2005 | WO2005066340A1 Process for producing streptokinase using genetically modified escherichia coli |
| 07/21/2005 | WO2005065267A2 Magnetophoretic cell clarification |
| 07/21/2005 | WO2005014823A3 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 07/21/2005 | WO2004096988A8 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050160490 Transgenic nematode expressing integration host factors (IHFs); bioreactor for heterologous gene expression[; antisense agents; gene transfer and propagation tool |
| 07/21/2005 | US20050159591 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050159588 Nucleotide sequences coding tumor-associated antigenic target polypeptides; diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159355 For treatment of inflammatory diseases |
| 07/21/2005 | US20050159350 Has superagonist properties and is used to stimulate cell division and treat wounds, ischemia, heart disease, neural injuries, peripheral vascular disease, gastric ulcers and duodenal ulcers |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158880 Cell patterning technique |
| 07/21/2005 | US20050158861 Yeast transformation vector containing auxotrophic dominant gene yeast transfomant containing it and their preparation |
| 07/21/2005 | US20050158860 Method for evolving a cell having desired phenotype and evolved cells |
| 07/21/2005 | US20050158844 Methods for eliminating or reducing the expression of a genes in a filamentous fungal strains |
| 07/21/2005 | US20050158843 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted |
| 07/21/2005 | US20050158838 Novel enterokinase cleavage sequences |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158825 Using fungal host as bioreactor for production of monoclonal antibodies |
| 07/21/2005 | US20050158818 Recombinant hydrolase for use in the preparation of 7-amino-cephalosporanic acid; bioreactors |
| 07/21/2005 | US20050158817 Method for the production of a fermentation product from an organism |
| 07/21/2005 | US20050158816 Using yeast model comprising aequorin reporter as tool in screening compound toxicity; bioassay and drug screening |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |
| 07/21/2005 | US20050158769 Using vector transformed cell as bioreactor vehicle for heterologous gene expression; directed protein evolution |
| 07/21/2005 | US20050158766 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 07/21/2005 | US20050158764 Alternatively spliced juvenile hormone receptor genes for use in identifying modulators for insect propagation; biological pest control |
| 07/21/2005 | US20050158762 Novel 2,5-diketo-L-gluconic acid reductases and methods of use |
| 07/21/2005 | US20050158749 Avermectin aglycon synthase genes |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158423 Method of improving food fermentation procedures |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158344 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158312 Related to the carboxylate transporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/21/2005 | US20050158294 isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals; preventing urinary tract ailments in companion animals; reducing levels of pathogenic Clostridia, Escherichia, Salmonella bacteria in the faeces |
| 07/21/2005 | US20050158293 Canine probiotic Lactobacilli |
| 07/21/2005 | US20050158292 Lactococcus induces production of IL-10 from mammalian dendritic or spleen cells; treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer) |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production |
| 07/21/2005 | US20050155400 With enhanced ability to fix nitrogen, decompose phosphorus and potassium minerals, decompose complex carbon compounds, over produce growth factors, and over produce ATP; culturing multiple yeasts in an electromagnetic field to become symbiotic and adapt to soil |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2551484A1 Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| 07/21/2005 | CA2549532A1 Bioluminescent assays and cells useful therein |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555320A2 Expression system derived from the lipase regulation cascade of Pseudomonas alcaligenes |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555317A1 Synthetic genes and genetic constructs comprising the same |
| 07/20/2005 | EP1555314A2 Enzymes and detergent compositions |
| 07/20/2005 | EP1554398A2 Apparatus and method for preparative scale purification of nucleic acids |
| 07/20/2005 | EP1554384A1 E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins , and method of manufacturing recombinant fabs |
| 07/20/2005 | EP1554378A2 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1554372A2 Natural promoters for gene expression in c1 metabolizing bacteria |
| 07/20/2005 | EP1554371A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/20/2005 | EP1554302A2 Methods and dna constructs for high yield production of polypeptides |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1210440B1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1163323B1 Biotechnological method for producing n-acetyl mannosamine |
| 07/20/2005 | EP0977878B1 Dna sequences coding for subunit chld of plant magnesium chelatases for determining their action |
| 07/20/2005 | EP0965637B1 Fas ANTIGEN DERIVATIVES |
| 07/20/2005 | EP0934407B1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 07/20/2005 | EP0929677B1 Recombinant method for preparing a complete malaria antigen gp190/msp1 |
| 07/20/2005 | EP0759075B1 Apoptosis regulating gene |
| 07/20/2005 | EP0703983B9 Regulation of plant growth |
| 07/20/2005 | CN1643160A Method and test strips for the measurement of fat loss during weight loss programs |
| 07/20/2005 | CN1643157A Improved method for the production of vitamin B12 |
| 07/20/2005 | CN1643156A Process for preparing conjugated linoleic acid |
| 07/20/2005 | CN1643152A Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 07/20/2005 | CN1643151A Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643141A Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 07/20/2005 | CN1643131A Method of continuous culture of anaerobic bacterium |
| 07/20/2005 | CN1643130A A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 07/20/2005 | CN1643129A Denatured spirulina and manufacturing method thereof |